12.85USD-2.50%Mkt Cap: 443.60M $P/E: 1285.001d ago
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphala…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap443.60M $
Enterprise Value355.21M $
Revenue (TTM)90.44M $
Gross Profit73.43M $
Net Income (TTM)2.70M $
Revenue/Share2.501 USD
Last Price12.85 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees156
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)1285.00
P/E (Forward)-25.20
PEG1.60
EV/EBITDA-268.69
EV/Revenue3.93
P/S4.90
P/B3.93
EPS (TTM)0.01
EPS (Forward)-0.51
52W Range
8.12084% of range13.74
52W High13.74 USD
52W Low8.120 USD
Profitability
Gross Margin86.16%
Oper. Margin-6.55%
EBITDA Margin-1.46%
Profit Margin3.17%
ROE2.43%
ROA2.18%
Growth
Revenue Growth26.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF22.52M $
CapEx (TTM)1.55M $
FCF Margin21.73%
FCF Yield4.43%
Net Debt-88.39M $
Net Debt/EBITDA66.86
Balance Sheet
Debt/Equity0.01
Current Ratio11.24
Quick Ratio9.72
Book Value/Sh3.270 USD
Cash/Share2.587 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateDec 24, 2019
Splits
Last Split1:700
Split DateDec 24, 2019
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)21.55 USD
Upside (mean)+67.7%
Target Range17.00 USD – 29.76 USD
$17.00+67.7% to mean$29.76
# Analysts5
Ownership
Shares Out.34.52M
Float28.60M
Insiders8.13%
Institutions49.02%
Short Interest
Short Ratio4.7d
Short % Float9.05%
Short % Out.8.31%
Shares Short2.87M
Short (prev mo.)3.11M
Technical
SMA 5011.76 (+9.3%)
SMA 20010.38 (+23.7%)
Beta0.49
S&P 52W Chg20.25%
Avg Vol (30d)501.38K
Avg Vol (10d)352.83K
Technical Indicators
RSI (14)55.9
MACD0.4494
MACD Signal0.4956
MACD Hist.-0.0461
BB Upper13.95 USD
BB Middle12.68 USD
BB Lower11.41 USD
BB Width20.10%
ATR (14)0.5648 USD
Vol Ratio (20d)0.81x